603590.SH
康辰药业
SSE · Healthcare · Biotechnology · CN
CNY 30.12
−6.49%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 24.61x
- P/E 2027E
- 21.60x
- P/E 2028E
- 18.42x
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 28.86x
- PEG TTM
- 1.62x
- Price / book
- 1.51x
- Price / sales
- 5.20x
- Price / cash flow
- 28.46x
Enterprise value
- Enterprise value
- CNY 5.0B
- EV / sales
- 5.47x
- EV / EBITDA
- 21.24x
- EV / EBIT
- 24.31x
- Market cap
- CNY 4.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026